206 related articles for article (PubMed ID: 21055615)
61. Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
Cantorias MV; Figueroa SD; Quinn TP; Lever JR; Hoffman TJ; Watkinson LD; Carmack TL; Cutler CS
Nucl Med Biol; 2009 Jul; 36(5):505-13. PubMed ID: 19520291
[TBL] [Abstract][Full Text] [Related]
62. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
Kukis DL; DeNardo SJ; DeNardo GL; O'Donnell RT; Meares CF
J Nucl Med; 1998 Dec; 39(12):2105-10. PubMed ID: 9867151
[TBL] [Abstract][Full Text] [Related]
63. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
[TBL] [Abstract][Full Text] [Related]
64. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer.
Rasaneh S; Rajabi H; Babaei MH; Daha FJ; Salouti M
Nucl Med Biol; 2009 May; 36(4):363-9. PubMed ID: 19423003
[TBL] [Abstract][Full Text] [Related]
65. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
66. Syntheses and evaluation of
Chakraborty S; Goswami D; Chakravarty R; Mohammed SK; Sarma HD; Dash A
Chem Biol Drug Des; 2018 Sep; 92(3):1618-1626. PubMed ID: 29729071
[TBL] [Abstract][Full Text] [Related]
67. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
[TBL] [Abstract][Full Text] [Related]
68. Exploring the radiosynthesis and in vitro characteristics of [
Jensen SB; Käkelä M; Jødal L; Moisio O; Alstrup AKO; Jalkanen S; Roivainen A
J Labelled Comp Radiopharm; 2017 Jul; 60(9):439-449. PubMed ID: 28556976
[TBL] [Abstract][Full Text] [Related]
69. DOTA-tetrazine probes with modified linkers for tumor pretargeting.
Läppchen T; Rossin R; van Mourik TR; Gruntz G; Hoeben FJM; Versteegen RM; Janssen HM; Lub J; Robillard MS
Nucl Med Biol; 2017 Dec; 55():19-26. PubMed ID: 29028502
[TBL] [Abstract][Full Text] [Related]
70. Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.
Eder M; Wängler B; Knackmuss S; LeGall F; Little M; Haberkorn U; Mier W; Eisenhut M
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1878-86. PubMed ID: 18509635
[TBL] [Abstract][Full Text] [Related]
71. Processing of generator-produced 68Ga for medical application.
Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
[TBL] [Abstract][Full Text] [Related]
72. Stabilization of (90)y-labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid.
Liu S; Edwards DS
Bioconjug Chem; 2001; 12(4):554-8. PubMed ID: 11459460
[TBL] [Abstract][Full Text] [Related]
73. Optimization of the radiolabelling method for improved in vitro and in vivo stability of
Aleksandar V; Drina J; Magdalena R; Zorana M; Marija M; Dragana S; Sanja VĐ
Appl Radiat Isot; 2020 Feb; 156():108984. PubMed ID: 31760344
[TBL] [Abstract][Full Text] [Related]
74. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
[TBL] [Abstract][Full Text] [Related]
75. Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue.
Asti M; Iori M; Capponi PC; Atti G; Rubagotti S; Martin R; Brennauer A; Müller M; Bergmann R; Erba PA; Versari A
Nucl Med Biol; 2014 Jan; 41(1):24-35. PubMed ID: 24183610
[TBL] [Abstract][Full Text] [Related]
76. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Konijnenberg MW; Bijster M; Krenning EP; De Jong M
J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
[TBL] [Abstract][Full Text] [Related]
77. Imaging, biodistribution and efficacy evaluation of
Chen LC; Chang YJ; Chen SJ; Lee WC; Chang CH; Lee TW; Shien JH
Int J Radiat Biol; 2017 May; 93(5):477-486. PubMed ID: 28045339
[TBL] [Abstract][Full Text] [Related]
78. Measurement of protein synthesis: in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H]tyrosine, and 2-fluoro-[ (3)H]tyrosine.
Eigner S; Beckford Vera DR; Fellner M; Loktionova NS; Piel M; Melichar F; Rösch F; Roß TL; Lebeda O; Henke KE
Recent Results Cancer Res; 2013; 194():269-83. PubMed ID: 22918764
[TBL] [Abstract][Full Text] [Related]
79. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
80. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
